Concord Neonatal, one of the ventures in NLC portfolio, has closed a new funding round, securing substantial funding with private investors. Concord Neonatal is improving birth, by offering solutions to give baby’s a shock-free birth. This new funding allows the company to expand sales internationally and continue to scale-up.
Recent news
INTRODUCING CONCORD BIRTH FLOW: BUILDING THE FUTURE OF CHILD BIRTH
PRESS RELEASE November 8, 2022 St. Antonius Hospital in the Netherlands leading the way with the Concord Birth Flow St. Antonius Hospital is the…
Read more
MINDAFFECT SELECTED FOR POLE POSITION PROGRAMME
October 11, 2022 PRESS RELEASE MindAffect selected for Pole Position Programme – DeepTech/Medical field MindAffect, a BCI/AI Healthtech company specializing in the development of…
Read more
INTRODUCING CRAINIO: REVOLUTIONISING THE MEASUREMENT OF INTRACRANIAL PRESSURE
PRESS RELEASE October 5, 2022 Crainio, an NLC venture, sets out to revolutionise the measurement of intracranial pressure (ICP) by developing a non-invasive measuring…
Read more